Related Experiment Video
Updated: Dec 9, 2025
Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration
Published on: May 19, 2023
Iron-containing pathologies of the spleen: magnetic resonance imaging features with pathologic correlation
Nikita Consul1, Sidra Javed-Tayyab2, Ajaykumar C Morani3
1Department of Diagnostic Radiology, Baylor College of Medicine, Houston, TX, 77030, USA.
Abstract:
Systemic and non-systemic pathologies that involve iron deposition within the spleen have characteristic features on MRI due to the susceptibility properties of deposited iron, or hemosiderin. These lesions will have signal loss on longer echo sequences due to the T2* effect when evaluated with dual-echo gradient-echo sequences. The pathophysiology of systemic and localized iron sequestration disease processes can elucidate an underlying diagnosis based on these imaging features in conjunction with clinical information.
Insights
MRI reveals spleen iron deposition (hemosiderin) causing signal loss on T2* sequences. Pathophysiology and imaging features help diagnose systemic and localized iron sequestration diseases.
Area of Science:
- Radiology
- Medical Imaging
- Pathophysiology
Background:
- Spleen pathologies can involve iron deposition.
- Deposited iron (hemosiderin) has unique magnetic susceptibility properties.
- These properties affect MRI signal intensity.
Purpose of the Study:
- To describe MRI features of splenic iron deposition.
- To correlate imaging findings with underlying pathologies.
- To aid in diagnosing iron sequestration diseases.
Main Methods:
- Utilized dual-echo gradient-echo MRI sequences.
- Evaluated signal loss on longer echo sequences (T2* effect).
- Correlated MRI findings with clinical information.
Main Results:
- Splenic iron deposition causes characteristic signal loss on MRI.
- This signal loss is more pronounced on longer echo sequences.
- T2* effects are key indicators of hemosiderin.
Conclusions:
- MRI, particularly dual-echo gradient-echo sequences, is effective in detecting splenic iron deposition.
- Imaging features of T2* signal loss aid in diagnosing iron sequestration diseases.
- Integrating imaging with clinical data enhances diagnostic accuracy.
